While both medications work in similar ways, they have different dosing schedules, insurance coverage, and side effects, all of which should be considered before making the switch
Dosing schedule: Treatment typically begins with 0.25 mg once weekly for four weeks
Contrary to Parkinson's disease, cognition typically remains intact
In a Phase 2 clinical trial published in the New England Journal of Medicine (2023), the compound demonstrated unprecedented metabolic effects: Average weight reduction: 24.2% of total body weight at 48 weeks (24mg dose)
According to a recent study on The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19 (1) glutathione levels in the body were directly linked to the severity of the inflammatory response in COVID-19 patients, with the most-severe responses among those with severely depleted levels irrespective of comorbidities (2,1)